Researchers Call for Kratom Regulation Over Bans
A new study distinguishes natural kratom leaf from synthetic derivatives as federal scheduling approaches next month.
Updated on Oct. 29, 2026 in Substance Abuse
Live Poll
Should the government regulate natural kratom rather than banning it entirely?
Seven researchers published a peer-reviewed paper in Frontiers in Pharmacology arguing that natural kratom leaf should be regulated rather than banned. The study emphasizes that evidence does not support scheduling natural leaf while pointing to safety risks from synthetic alternatives.
Why it matters
The findings challenge federal approaches to kratom policy by differentiating between traditional botanical use and the newer market of concentrated synthetic products. This distinction is critical as federal regulators prepare to implement new rules for synthetic derivatives.
Natural kratom leaf contains 7-OH at levels of 0.003% to 0.04% by weight, far lower than semi-synthetic products introduced in 2023. Currently, 23 states regulate natural leaf while maintaining bans on concentrated synthetic derivatives.
The players
DEA
The Drug Enforcement Administration is the primary federal agency responsible for enforcing controlled substances laws in the United States.
FDA
The Food and Drug Administration is the federal agency tasked with protecting public health by ensuring the safety and efficacy of substances in the marketplace.
The details
The researchers analyzed historical use, clinical evidence, and preclinical data to conclude that banning natural kratom is not supported by findings. The paper highlights that concentrated synthetic 7-OH products pose specific risks, including potential respiratory depression, which contrasts with the traditional consumption profile of natural leaf.
Timeline
Late 2023: Semi-synthetic 7-OH products entered the market.
July 2025: The FDA recommended scheduling concentrated synthetic 7-OH.
August 26, 2026: DEA temporary scheduling of synthetic 7-OH took effect.
October 22, 2026: The research paper was published in Frontiers in Pharmacology.
November 13, 2026: A DEA proposal covering concentrated synthetic 7-OH goes into effect.
Health Landscape
This paper marks a departure from the current federal trajectory established by the DEA's temporary scheduling of three synthetic 7-OH derivatives. It suggests that scientific consensus may diverge from blanket regulatory approaches that fail to distinguish between botanical and synthetic alkaloids.
The potential reclassification of synthetic kratom products could change market availability and safety warnings for consumers. Individuals should remain aware of state-level regulations, as 23 states currently have specific laws governing natural kratom use.
The takeaway
The study suggests that distinguishing between botanical materials and chemically concentrated synthetics is essential for creating effective policy. Consumers are encouraged to verify the regulatory status of kratom products in their specific state to ensure compliance with local laws.
What happens next
A DEA proposal covering concentrated synthetic 7-OH is scheduled to go into effect on November 13, 2026.
Further reading
Learn more about the latest research and policy updates in the Substance Abuse section.
More information
View the federal officials and researchers video for additional context on this topic.
Live Poll
Should the government regulate natural kratom rather than banning it entirely?
